Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Canonical WNT signaling components in vascular development and barrier formation
Yulian Zhou, … , Makoto M. Taketo, Jeremy Nathans
Yulian Zhou, … , Makoto M. Taketo, Jeremy Nathans
Published August 1, 2014
Citation Information: J Clin Invest. 2014;124(9):3825-3846. https://doi.org/10.1172/JCI76431.
View: Text | PDF
Research Article Vascular biology

Canonical WNT signaling components in vascular development and barrier formation

  • Text
  • PDF
Abstract

Canonical WNT signaling is required for proper vascularization of the CNS during embryonic development. Here, we used mice with targeted mutations in genes encoding canonical WNT pathway members to evaluate the exact contribution of these components in CNS vascular development and in specification of the blood-brain barrier (BBB) and blood-retina barrier (BRB). We determined that vasculature in various CNS regions is differentially sensitive to perturbations in canonical WNT signaling. The closely related WNT signaling coreceptors LDL receptor–related protein 5 (LRP5) and LRP6 had redundant functions in brain vascular development and barrier maintenance; however, loss of LRP5 alone dramatically altered development of the retinal vasculature. The BBB in the cerebellum and pons/interpeduncular nuclei was highly sensitive to decrements in canonical WNT signaling, and WNT signaling was required to maintain plasticity of barrier properties in mature CNS vasculature. Brain and retinal vascular defects resulting from ablation of Norrin/Frizzled4 signaling were ameliorated by stabilizing β-catenin, while inhibition of β-catenin–dependent transcription recapitulated the vascular development and barrier defects associated with loss of receptor, coreceptor, or ligand, indicating that Norrin/Frizzled4 signaling acts predominantly through β-catenin–dependent transcriptional regulation. Together, these data strongly support a model in which identical or nearly identical canonical WNT signaling mechanisms mediate neural tube and retinal vascularization and maintain the BBB and BRB.

Authors

Yulian Zhou, Yanshu Wang, Max Tischfield, John Williams, Philip M. Smallwood, Amir Rattner, Makoto M. Taketo, Jeremy Nathans

×

Figure 10

Transcriptionally inactive β-catenin cannot support normal retinal vascular development and BBB/BRB integrity.

Options: View larger image (or click on image) Download as PowerPoint
Transcriptionally inactive β-catenin cannot support normal retinal vascu...
(A and B) Brains from P10 Ctnnb1CKO/dm (control) and Ctnnb1CKO/dm Pdgfb-CreER mice treated with 60 μg 4HT at P6. Right panels, coronal sections at the anterior hippocampus (left), the pons (center), and the cerebellum (right). Enlarged images (left) show Claudin5 and PLVAP in the cerebral cortical vasculature, corresponding to the white rectangles (center). Ctnnb1CKO/dm brains show PLVAP–Claudin5+ vasculature and no sulfo-NHS-biotin leakage. Ctnnb1CKO/dm Pdgfb-CreER vasculature shows many PLVAP+Claudin5– ECs and extensive sulfo-NHS-biotin leakage. Scale bars: 500 μm (left panels); 2 mm (right panels). (C) Flat-mount retinas from P10 Ctnnb1CKO/+ Pdgfb-CreER, Ctnnb1CKO/dm, and Ctnnb1CKO/dm Pdgfb-CreER mice treated with 50 to 100 μg 4HT at P6. Upper row, the BRB is compromised in Ctnnb1CKO/dm Pdgfb-CreER retinas. Bottom row, retinal vasculature color coded by depth. Ctnnb1CKO/dm Pdgfb-CreER retinas have far fewer deep retinal capillaries. Scale bar: 400 μm. (D) Flat-mount retinas from P10 Ctnnb1CKO/dm (control) and Ctnnb1CKO/dm Pdgfb-CreER mice treated with 60 μg 4HT at P6. Ctnnb1CKO/dm Pdgfb-CreER retinas show efficient conversion of vein and capillary ECs from PLVAP–Claudin5+ to PLVAP+Claudin5–. Low levels of PLVAP in Ctnnb1CKO/dm capillaries are due to heterozygosity for Ctnnb1. Scale bar: 500 μm. (E) Cross sections of P10 retinas from control Ctnnb1CKO/+ Pdgfb-CreER (upper panels) and Ctnnb1CKO/dm Pdgfb-CreER mice (lower panels) treated with 50 to 100 μg 4HT at P6. Ctnnb1CKO/dm Pdgfb-CreER retinas show extensive vascular leakage in the IPL (arrows in the Sulfo-NHS-biotin panel) and lack deep retinal capillaries (arrows in the GS-lectin panels). Scale bar: 200 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts